Upgrade to SI Premium - Free Trial

Celanese Corporation Reports First Quarter Earnings

May 5, 2026 4:15 PM

DALLAS--(BUSINESS WIRE)-- Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today reported first quarter 2026 U.S. GAAP diluted earnings per share of $0.41 and adjusted earnings per share of $0.85. Net sales of $2.3 billion increased 6 percent sequentially, reflecting a 5 percent increase in volume, a small currency benefit and stable pricing. Results reflected actions that delivered favorable product mix and cost productivity measures in Engineered Materials, along with deliberate steps to capture higher value opportunities within the Acetyl Chain. These benefits were partially offset by higher feedstock and energy costs across both businesses.

Celanese utilized its fundamentally strong and differentiated business models to take swift action and capitalize on opportunities. For the first quarter, the Company reported consolidated operating profit of $214 million, adjusted EBIT of $275 million, and operating EBITDA of $455 million at margins of 9, 12, and 20 percent, respectively.

Celanese continued to take actions to advance the strategic priorities of increasing cash flow to accelerate deleveraging, intensifying cost improvements, and driving top line growth. These actions included the successful restart of the Frankfurt, Germany VAM unit and the announcement of the intended closure of the nylon 6,6 polymerization unit in Singapore.

“We are taking decisive and intentional actions to drive business improvement,” said Scott Richardson, president and chief executive officer. “By staying ahead of dynamic global events, we were able to capitalize on opportunities while positioning the business for an improved earnings profile over the course of the year. At the same time, we are strengthening the long-term fundamentals of the business through operational improvements and increased resilience. This progress supports our decision to raise our full‑year free cash flow outlook to $700 to $800 million and reinforces our confidence in the path forward.”

First Quarter 2026 Financial Highlights:

Three Months Ended

March 31,
2026

December 31,
2025

March 31,
2025

(unaudited)

(In $ millions, except per share data)

Net Sales

Engineered Materials

1,325

1,277

1,287

Acetyl Chain

1,036

940

1,116

Intersegment Eliminations

(24)

(13)

(14)

Total

2,337

2,204

2,389

Operating Profit (Loss)

Engineered Materials

221

111

94

Acetyl Chain

95

90

161

Other Activities

(102)

(108)

(90)

Total

214

93

165

Net Earnings (Loss)

48

22

(20)

Adjusted EBIT(1)

Engineered Materials

220

183

124

Acetyl Chain

131

146

167

Other Activities

(76)

(78)

(60)

Total

275

251

231

Equity Earnings and Dividend Income, Other Income (Expense)

Engineered Materials

32

32

17

Acetyl Chain

2

42

3

Operating EBITDA(1)

455

435

411

Diluted EPS - continuing operations

$

0.41

$

0.23

$

(0.17)

Diluted EPS - total

$

0.40

$

0.17

$

(0.22)

Adjusted EPS(1)

$

0.85

$

0.67

$

0.54

Net cash provided by (used in) investing activities

425

(104)

(98)

Net cash provided by (used in) financing activities

(3)

(324)

45

Net cash provided by (used in) operating activities

76

252

37

Free cash flow(1)

3

160

(73)

(1) See "Non-US GAAP Financial Measures" below.

Recent Highlights:

First Quarter Business Segment Overview

Engineered Materials

Engineered Materials reported first quarter net sales of $1.3 billion, a 4 percent sequential increase, consisting of 3 percent higher volume with no change in pricing and a modest currency benefit. Results were supported by seasonal volume improvement and favorable product and regional mix, partially offset by continued softness in certain end markets, particularly automotive in China. The business reported first quarter operating profit of $221 million, adjusted EBIT of $220 million, and operating EBITDA of $324 million, with margins of 17, 17, and 25 percent, respectively. Performance reflected continued execution of strategic initiatives focused on product and market segment positioning, improvements in pipeline quality and diversification, value-based pricing, and cost reduction, leading to favorable mix. During the quarter, the business advanced a series of structural actions under its Grow and Fortify strategy, such as the repositioning of the nylon portfolio and targeted network enhancements including liquid crystal polymers capabilities in Asia, specialty compounding in Europe, and medical-grade compounding in Asia. These actions strengthen the operational foundation in concert with business diversification and breadth into higher-growth end markets such as electronics, data center server componentry, medical devices, and electric vehicles.

Acetyl Chain

The Acetyl Chain reported first quarter net sales of $1.0 billion, a 10 percent sequential increase, consisting of increases of 8 percent in volume and 1 percent in price, with a small currency benefit. Results were supported by late‑quarter pricing and volume opportunities, primarily in China, partially offset by higher feedstock costs and continued softness in acetate tow. The business delivered first quarter operating profit of $95 million, adjusted EBIT of $131 million, and operating EBITDA of $194 million at margins of 9, 13, and 19 percent, respectively. Performance highlighted the agility of the globally integrated operating model, as the business responded swiftly through targeted pricing actions, proactive feedstock management, and dynamic network optimization. The business took multiple actions during the quarter, including the accelerated restart of the Frankfurt VAM unit, commissioning of the VAE reactor, and optimization of asset utilization across the U.S. and Asia. These actions enabled the Acetyl Chain to mitigate cost inflation, capture high value opportunities, and reinforce its position as a reliable supplier.

Cash Flow and Tax

Celanese reported first quarter operating cash flow of $76 million and free cash flow of $3 million. First quarter operating and free cash flow results reflected expected seasonal working capital timing effects and disciplined capital spending, along with changes in the timing of interest payments.

The effective U.S. GAAP income tax rate for the first quarter was 40 percent, which was higher compared to the same period in 2025, primarily due to increased forecasted earnings for the current year, changes in uncertain tax benefits related to prior year tax examinations, and difference in functional currencies for tax purposes in certain jurisdictions.

The effective tax rate for 2026 adjusted earnings was 8 percent for the first quarter. We anticipate this rate for the full year 2026 based on expected jurisdictional earnings mix for the full year and consideration of other non-recurring U.S. GAAP items.

Outlook

"We are uniquely positioned to create and capture opportunities, and as we move into the second quarter, we expect meaningful sequential improvement driven by stronger volumes and price increase realization in the Acetyl Chain, along with pricing improvements in Engineered Materials and seasonal demand across both businesses." continued Richardson. "Based on this, we expect second quarter adjusted earnings per share to be $2.00 to $2.40. We are currently estimating adjusted earnings per share of approximately $3.00 per share in the second half of 2026 as we continue to advance actions to enhance our commercial capabilities and cost structure."

“These actions are expected to strengthen earnings in 2026, meaningfully accelerate deleveraging, and bring our net debt to operating EBITDA ratio into the vicinity of 4.8x. Across market cycles, execution of our priorities positions Celanese for stronger resilience and more sustainable long‑term performance,” Richardson concluded.

Reconciliations of forecasted non-GAAP measures such as adjusted earnings per share, adjusted EBIT, operating EBITDA or free cash flow to the equivalent U.S. GAAP measures (diluted earnings per share, net earnings (loss) attributable to Celanese Corporation and net cash provided by (used in) operations, respectively), are not available without unreasonable efforts because a forecast of Certain Items, such as mark-to-market pension gains/losses, and other items is not practical. For more information, see "Non-GAAP Financial Measures" below.

The Company's prepared remarks related to the first quarter will be posted on its website at investors.celanese.com under Financial Information/Financial Document Library on May 5, 2026. Information about Non-US GAAP measures is included in a Non-US GAAP Financial Measures and Supplemental Information document posted on our investor relations website under Financial Information/Non-GAAP Financial Measures. See also "Non-GAAP Financial Measures" below.

Celanese Corporation is a global leader in chemistry, producing specialty material solutions used across most major industries and consumer applications. Our businesses use our chemistry, technology and commercial expertise to create value for our customers, employees and shareholders. We support sustainability by responsibly managing the materials we create and growing our portfolio of sustainable products to meet customer and societal demand. We strive to make a positive impact in our communities and to foster inclusivity across our teams. Celanese Corporation is a Fortune 500 company that employs more than 11,000 employees worldwide with 2025 net sales of $9.5 billion.

Forward-Looking Statements

This release may contain "forward-looking statements," which include information concerning the Company's plans, objectives, goals, strategies, future revenues, cash flow, financial performance, synergies, capital expenditures, deleveraging efforts, planned cost reductions, dividend policy, financing needs and other information that is not historical information. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the Company will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the results expressed or implied in the forward-looking statements contained in this release. These risks and uncertainties include, among other things: the ability to successfully achieve planned cost reductions; changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate; the length and depth of product and industry business cycles, particularly in the automotive, electrical, textiles, electronics and construction industries; potential liability resulting from pending or future claims or litigation, including investigations or enforcement actions, or from changes in the laws, regulations or policies of governments or other governmental activities, in the countries in which we operate; our level of indebtedness and our financial condition, each of which could diminish our ability to raise additional capital to fund operations, reduce our business and strategic flexibility, increase our interest expense, limit the success of our deleveraging efforts, and impact changes to our credit ratings, which could increase our interest expense in the event of additional downgrades; volatility or changes in the price and availability of raw materials and energy, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, carbon monoxide, wood pulp, hexamethylene diamine, Polyamide 66 ("PA66"), polybutylene terephthalate, ethanol, natural gas and fuel oil, and the prices for electricity and other energy sources; the ability to pass increases in raw materials prices, logistics costs and other costs on to customers or otherwise improve margins through price increases; the possibility that we will not be able to realize the anticipated benefits of the Mobility & Materials business (the "M&M Business") we acquired from DuPont de Nemours, Inc. (the "M&M Acquisition"), including synergies and growth opportunities, whether as a result of difficulties arising from the operation of the M&M Business or other unanticipated delays, costs, inefficiencies or liabilities; additional impairment of goodwill or intangible assets; increased commercial, legal or regulatory complexity of entering into, or expanding our exposure to, certain end markets and geographies; risks in the global economy and equity and credit markets and their potential impact on our ability to pay down debt in the future and/or refinance at suitable rates, in a timely manner, or at all; the ability to maintain plant utilization rates and to implement planned capacity additions, expansions and maintenance; the ability to reduce or maintain current levels of production costs and to improve productivity by implementing technological improvements to existing plants; increased price competition and the introduction of competing products by other companies; the ability to identify desirable potential acquisition or divestiture opportunities and to complete such transactions, including obtaining regulatory approvals, consistent with the Company's strategy; market acceptance of our products and technology; compliance and other costs and potential disruption or interruption of production or operations due to accidents, interruptions in sources of raw materials, transportation, logistics or supply chain disruptions, cybersecurity incidents, AI-related vulnerabilities, terrorism or political unrest, public health crises, or other unforeseen events or delays in construction or operation of facilities, including as a result of geopolitical conditions, the direct or indirect consequences of acts of war or conflict (such as the Russia-Ukraine conflict or conflicts in the Middle East) or terrorist incidents or as a result of fire, flood, hurricanes, other severe weather, natural disasters, other catastrophic events, or other crises; the ability to obtain governmental approvals and to construct facilities on terms and schedules acceptable to the Company; changes in applicable tariffs, duties, treaties and trade agreements, tax rates or legislation throughout the world including, but not limited to, anti-dumping and countervailing duties, adjustments, changes in estimates or interpretations or the resolution of tax examinations or audits that may impact recorded or future tax impacts and potential regulatory and legislative tax developments in the United States and other jurisdictions; changes in the degree of intellectual property and other legal protection afforded to our products or technologies, or the theft of such intellectual property; potential liability for remedial actions and increased costs under existing or future environmental, health and safety regulations, including those relating to climate change or other sustainability matters; changes in currency exchange rates and interest rates; tax rates and changes thereto; and various other factors discussed from time to time in the Company's filings with the Securities and Exchange Commission.

Any forward-looking statement speaks only as of the date on which it is made, and the Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.

Non-GAAP Financial Measures

Presentation

This document presents the Company's two business segments, Engineered Materials and the Acetyl Chain.

Use of Non-US GAAP Financial Information

This release uses the following Non-US GAAP measures: adjusted EBIT, adjusted EBIT margin, operating EBITDA, operating EBITDA margin, adjusted earnings per share and free cash flow. These measures are not recognized in accordance with US GAAP and should not be viewed as an alternative to US GAAP measures of performance or liquidity. The most directly comparable financial measure presented in accordance with US GAAP in our consolidated financial statements for adjusted EBIT and operating EBITDA is net earnings (loss) attributable to Celanese Corporation; for adjusted EBIT margin is operating margin; for operating EBITDA margin is operating margin; for adjusted earnings per share is earnings (loss) from continuing operations attributable to Celanese Corporation per common share-diluted; and for free cash flow is net cash provided by (used in) operations.

Definitions of Non-US GAAP Financial Measures

Note: The income tax expense (benefit) on Certain Items ("Non-GAAP adjustments") is determined using the applicable rates in the taxing jurisdictions in which the Non-GAAP adjustments occurred and includes both current and deferred income tax expense (benefit). The income tax rate used for adjusted earnings per share approximates the midpoint in a range of forecasted tax rates for the year. This range may include certain partial or full-year forecasted tax opportunities and related costs, where applicable, and specifically excludes changes in uncertain tax positions, discrete recognition of GAAP items on a quarterly basis, other pre-tax items adjusted out of our GAAP earnings for adjusted earnings per share purposes and changes in management's assessments regarding the ability to realize deferred tax assets for GAAP. In determining the adjusted earnings per share tax rate, we reflect the impact of foreign tax credits when utilized, or expected to be utilized, absent discrete events impacting the timing of foreign tax credit utilization. We analyze this rate quarterly and adjust it if there is a material change in the range of forecasted tax rates; an updated forecast would not necessarily result in a change to our tax rate used for adjusted earnings per share. The adjusted tax rate is an estimate and may differ from the actual tax rate used for GAAP reporting in any given reporting period. Table 3a of our Non-US GAAP Financial Measures and Supplemental Information document summarizes the reconciliation of our estimated GAAP effective tax rate to the adjusted tax rate. The estimated GAAP rate excludes discrete recognition of GAAP items due to our inability to forecast such items. As part of the year-end reconciliation, we will update the reconciliation of the GAAP effective tax rate to the adjusted tax rate for actual results.

Reconciliation of Non-US GAAP Financial Measures

Reconciliations of the Non-US GAAP financial measures used in this press release to the comparable US GAAP financial measure, together with information about the purposes and uses of Non-US GAAP financial measures, are included in our Non-US GAAP Financial Measures and Supplemental Information document filed as an exhibit to our Current Report on Form 8-K filed with the SEC on or about May 5, 2026 and also available on our website at investors.celanese.com under Financial Information/Financial Document Library.

Results Unaudited

The results in this document, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year.

Certain prior period amounts have been revised to correct for certain prior period immaterial errors. See Note 1 to our Quarterly Report on Form 10-Q for the quarterly period ending March 31, 2026.

Supplemental Information

Additional information about our prior period performance is included in our Quarterly Reports on Form 10-Q and in our Non-US GAAP Financial Measures and Supplemental Information document.

Consolidated Statements of Operations - Unaudited

Three Months Ended

March 31,
2026

December 31,
2025

March 31,
2025

(In $ millions, except share and per share data)

Net sales

2,337

2,204

2,389

Cost of sales

(1,869)

(1,781)

(1,915)

Gross profit

468

423

474

Selling, general and administrative expenses

(226)

(223)

(231)

Amortization of intangible assets

(40)

(40)

(40)

Research and development expenses

(28)

(32)

(31)

Other (charges) gains, net

(20)

(39)

(31)

Foreign exchange gain (loss), net

12

7

21

Gain (loss) on disposition of businesses and assets, net

48

(3)

3

Operating profit (loss)

214

93

165

Equity in net earnings (loss) of affiliates

35

37

22

Non-operating pension and other postretirement employee benefit (expense) income

5

50

2

Interest expense

(183)

(177)

(170)

Refinancing expense

(36)

(32)

Interest income

9

6

4

Dividend income - equity investments

1

40

1

Other income (expense), net

1

2

Earnings (loss) from continuing operations before tax

82

13

(6)

Income tax (provision) benefit

(33)

15

(9)

Earnings (loss) from continuing operations

49

28

(15)

Earnings (loss) from operation of discontinued operations

(1)

(8)

(6)

Income tax (provision) benefit from discontinued operations

2

1

Earnings (loss) from discontinued operations

(1)

(6)

(5)

Net earnings (loss)

48

22

(20)

Net (earnings) loss attributable to noncontrolling interests

(4)

(3)

(4)

Net earnings (loss) attributable to Celanese Corporation

44

19

(24)

Amounts attributable to Celanese Corporation

Earnings (loss) from continuing operations

45

25

(19)

Earnings (loss) from discontinued operations

(1)

(6)

(5)

Net earnings (loss)

44

19

(24)

Earnings (loss) per common share - basic

Continuing operations

0.41

0.23

(0.17)

Discontinued operations

(0.01)

(0.06)

(0.05)

Net earnings (loss) - basic

0.40

0.17

(0.22)

Earnings (loss) per common share - diluted

Continuing operations

0.41

0.23

(0.17)

Discontinued operations

(0.01)

(0.06)

(0.05)

Net earnings (loss) - diluted

0.40

0.17

(0.22)

Weighted average shares (in millions)

Basic

109.7

109.6

109.4

Diluted

110.0

109.8

109.4

Consolidated Balance Sheets - Unaudited

As of
March 31,
2026

As of
December 31,
2025

(In $ millions)

ASSETS

Current Assets

Cash and cash equivalents

1,758

1,263

Trade receivables - third party and affiliates, net

1,097

922

Non-trade receivables, net

583

545

Inventories

2,284

2,220

Assets held for sale

492

Other assets

247

251

Total current assets

5,969

5,693

Investments in affiliates

1,227

1,252

Property, plant and equipment, net

4,938

5,076

Operating lease right-of-use assets

376

359

Deferred income taxes

1,341

1,359

Other assets

608

601

Goodwill

4,157

4,171

Intangible assets, net

3,119

3,184

Total assets

21,735

21,695

LIABILITIES AND EQUITY

Current Liabilities

Short-term borrowings and current installments of long-term debt - third party and affiliates

1,741

1,204

Trade payables - third party and affiliates

1,441

1,279

Liabilities held for sale

75

Other liabilities

1,040

1,049

Income taxes payable

94

76

Total current liabilities

4,316

3,683

Long-term debt, net of unamortized deferred financing costs

10,813

11,394

Deferred income taxes

512

512

Uncertain tax positions

225

208

Benefit obligations

332

344

Operating lease liabilities

275

265

Other liabilities

777

817

Commitments and Contingencies

Shareholders' Equity

Treasury stock, at cost

(5,482)

(5,482)

Additional paid-in capital

439

431

Retained earnings

9,917

9,876

Accumulated other comprehensive income (loss), net

(811)

(776)

Total Celanese Corporation shareholders' equity

4,063

4,049

Noncontrolling interests

422

423

Total equity

4,485

4,472

Total liabilities and equity

21,735

21,695

Non-U.S. GAAP Financial Measures and Supplemental Information

May 5, 2026

In this document, the terms the "Company," "we" and "our" refer to Celanese Corporation and its subsidiaries on a consolidated basis.

Purpose

The purpose of this document is to provide information of interest to investors, analysts and other parties including supplemental financial information and reconciliations and other information concerning our use of non-U.S. GAAP financial measures. This document is updated quarterly.

Presentation

This document presents the Company's two business segments, Engineered Materials and the Acetyl Chain.

Use of Non-U.S. GAAP Financial Measures

From time to time, management may publicly disclose certain numerical "non-GAAP financial measures" in the course of our earnings releases, financial presentations, earnings conference calls, investor and analyst meetings and otherwise. For these purposes, the Securities and Exchange Commission ("SEC") defines a "non-GAAP financial measure" as a numerical measure of historical or future financial performance, financial position or cash flows that excludes amounts, or is subject to adjustments that effectively exclude amounts, included in the most directly comparable measure calculated and presented in accordance with U.S. GAAP, and vice versa for measures that include amounts, or are subject to adjustments that effectively include amounts, that are excluded from the most directly comparable U.S. GAAP measure so calculated and presented. For these purposes, "GAAP" refers to generally accepted accounting principles in the United States.

Non-GAAP financial measures disclosed by management are provided as additional information to investors, analysts and other parties because the Company believes them to be important supplemental measures for assessing our financial and operating results and as a means to evaluate our financial condition and period-to-period comparisons. These non-GAAP financial measures should be viewed as supplemental to, and should not be considered in isolation or as alternatives to, net earnings (loss), operating profit (loss), operating margin, cash flow from operating activities (together with cash flow from investing and financing activities), earnings per share or any other U.S. GAAP financial measure. These non-GAAP financial measures should be considered within the context of our complete audited and unaudited financial results for the given period, which are available on the Financial Information/Financial Document Library page of our website, investors.celanese.com. The definition and method of calculation of the non-GAAP financial measures used herein may be different from other companies' methods for calculating measures with the same or similar titles. Investors, analysts and other parties should understand how another company calculates such non-GAAP financial measures before comparing the other company's non-GAAP financial measures to any of our own. These non-GAAP financial measures may not be indicative of the historical operating results of the Company nor are they intended to be predictive or projections of future results.

Pursuant to the requirements of SEC Regulation G, whenever we refer to a non-GAAP financial measure, we will also present in this document, in the presentation itself or on a Form 8-K in connection with the presentation on the Financial Information/Financial Document Library page of our website, investors.celanese.com, to the extent practicable, the most directly comparable financial measure calculated and presented in accordance with GAAP, along with a reconciliation of the differences between the non-GAAP financial measure we reference and such comparable GAAP financial measure.

This document includes definitions and reconciliations of non-GAAP financial measures used from time to time by the Company.

Specific Measures Used

This document provides information about the following non-GAAP measures: adjusted EBIT, adjusted EBIT margin, operating EBITDA, operating EBITDA margin, operating profit (loss) attributable to Celanese Corporation, adjusted earnings per share, net debt, free cash flow and return on invested capital (adjusted). The most directly comparable financial measure presented in accordance with U.S. GAAP in our consolidated financial statements for adjusted EBIT and operating EBITDA is net earnings (loss) attributable to Celanese Corporation; for adjusted EBIT margin and operating EBITDA margin is operating margin; for operating profit (loss) attributable to Celanese Corporation is operating profit (loss); for adjusted earnings per share is earnings (loss) from continuing operations attributable to Celanese Corporation per common share-diluted; for net debt is total debt; for free cash flow is net cash provided by (used in) operations; and for return on invested capital (adjusted) is net earnings (loss) attributable to Celanese Corporation divided by the sum of the average of beginning and end of the year short- and long-term debt and Celanese Corporation shareholders' equity.

Definitions

Supplemental Information

Supplemental Information we believe to be of interest to investors, analysts and other parties includes the following:

Results Unaudited

The results in this document, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year.

Certain prior period amounts have been revised to correct for certain prior period immaterial errors. See Note 1 to our Quarterly Report on Form 10-Q for the quarterly period ending March 31, 2026.

Table 1

Adjusted EBIT and Operating EBITDA - Reconciliation of Non-GAAP Measures - Unaudited

Q1 '26

2025

Q4 '25

Q3 '25

Q2 '25

Q1 '25

(In $ millions)

Net earnings (loss) attributable to Celanese Corporation

44

(1,165

)

19

(1,357

)

197

(24

)

(Earnings) loss from discontinued operations

1

21

6

10

5

Interest income

(9

)

(24

)

(6

)

(7

)

(7

)

(4

)

Interest expense

183

701

177

177

177

170

Refinancing expense

68

36

32

Income tax provision (benefit)

33

(90

)

(15

)

(7

)

(77

)

9

Certain Items attributable to Celanese Corporation (Table 8)

23

1,639

34

1,520

42

43

Adjusted EBIT

275

1,150

251

326

342

231

Depreciation and amortization expense(1)

180

743

184

191

188

180

Operating EBITDA

455

1,893

435

517

530

411

Q1 '26

2025

Q4 '25

Q3 '25

Q2 '25

Q1 '25

(In $ millions)

Engineered Materials

3

6

1

3

2

Acetyl Chain

18

11

11

Other Activities(2)

Accelerated depreciation and amortization expense

21

17

12

3

2

Depreciation and amortization expense(1)

180

743

184

191

188

180

Total depreciation and amortization expense

201

760

196

194

190

180

______________________________

(1)

Excludes accelerated depreciation and amortization expense as detailed in the table above, which amounts are included in Certain Items above.

(2)

Other Activities includes corporate Selling, general and administrative ("SG&A") expenses, results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).

Table 2

Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited

Q1 '26

2025

Q4 '25

Q3 '25

Q2 '25

Q1 '25

(In $ millions, except percentages)

Operating Profit (Loss) / Operating Margin

Engineered Materials

221

16.7

%

(958

)

(17.8

)%

111

8.7

%

(1,327

)

(95.9

)%

164

11.4

%

94

7.3

%

Acetyl Chain

95

9.2

%

539

12.7

%

90

9.6

%

135

12.7

%

153

13.7

%

161

14.4

%

Other Activities(1)

(102

)

(367

)

(108

)

(83

)

(86

)

(90

)

Total

214

9.2

%

(786

)

(8.2

)%

93

4.2

%

(1,275

)

(52.7

)%

231

9.1

%

165

6.9

%

Less: Net Earnings (Loss) Attributable to NCI for Engineered Materials

2

6

3

1

2

Less: Net Earnings (Loss) Attributable to NCI for Acetyl Chain

2

8

3

1

2

2

Operating Profit (Loss) Attributable to Celanese Corporation

210

9.0

%

(800

)

(8.4

)%

90

4.1

%

(1,279

)

(52.9

)%

228

9.0

%

161

6.7

%

Operating Profit (Loss) / Operating Margin Attributable to Celanese Corporation

Engineered Materials

219

16.5

%

(964

)

(17.9

)%

111

8.7

%

(1,330

)

(96.1

)%

163

11.3

%

92

7.1

%

Acetyl Chain

93

9.0

%

531

12.5

%

87

9.3

%

134

12.6

%

151

13.5

%

159

14.2

%

Other Activities(1)

(102

)

(367

)

(108

)

(83

)

(86

)

(90

)

Total

210

9.0

%

(800

)

(8.4

)%

90

4.1

%

(1,279

)

(52.9

)%

228

9.0

%

161

6.7

%

Equity Earnings and Dividend Income, Other Income (Expense) Attributable to Celanese Corporation

Engineered Materials

32

109

32

35

25

17

Acetyl Chain

2

132

42

44

43

3

Other Activities(1)

3

15

3

4

3

5

Total

37

256

77

83

71

25

Non-Operating Pension and Other Post-Retirement Employee Benefit (Expense) Income Attributable to Celanese Corporation

Engineered Materials

3

3

Acetyl Chain

Other Activities(1)

5

52

47

2

1

2

Total

5

55

50

2

1

2

Certain Items Attributable to Celanese Corporation (Table 8)

Engineered Materials

(31

)

1,572

37

1,495

25

15

Acetyl Chain

36

32

17

9

1

5

Other Activities(1)

18

35

(20

)

16

16

23

Total

23

1,639

34

1,520

42

43

Adjusted EBIT / Adjusted EBIT Margin

Engineered Materials

220

16.6

%

720

13.4

%

183

14.3

%

200

14.5

%

213

14.8

%

124

9.6

%

Acetyl Chain

131

12.6

%

695

16.4

%

146

15.5

%

187

17.6

%

195

17.5

%

167

15.0

%

Other Activities(1)

(76

)

(265

)

(78

)

(61

)

(66

)

(60

)

Total

275

11.8

%

1,150

12.0

%

251

11.4

%

326

13.5

%

342

13.5

%

231

9.7

%

______________________________

(1)

Other Activities includes corporate SG&A expenses, results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).

Table 2

Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited (cont.)

Q1 '26

2025

Q4 '25

Q3 '25

Q2 '25

Q1 '25

(In $ millions, except percentages)

Depreciation and Amortization Expense(1)

Engineered Materials

104

441

105

115

112

109

Acetyl Chain

63

252

64

63

64

61

Other Activities(2)

13

50

15

13

12

10

Total

180

743

184

191

188

180

Operating EBITDA / Operating EBITDA Margin

Engineered Materials

324

24.5

%

1,161

21.5

%

288

22.6

%

315

22.8

%

325

22.5

%

233

18.1

%

Acetyl Chain

194

18.7

%

947

22.4

%

210

22.3

%

250

23.6

%

259

23.2

%

228

20.4

%

Other Activities(2)

(63

)

(215

)

(63

)

(48

)

(54

)

(50

)

Total

455

19.5

%

1,893

19.8

%

435

19.7

%

517

21.4

%

530

20.9

%

411

17.2

%

______________________________

(1)

Excludes accelerated depreciation and amortization expense, which amounts are included in Certain Items above. See Table 1 for details.

(2)

Other Activities includes corporate SG&A expenses, results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).

Table 3

Adjusted Earnings (Loss) per Share - Reconciliation of a Non-GAAP Measure - Unaudited

Q1 '26

2025

Q4 '25

Q3 '25

Q2 '25

Q1 '25

per

share

per

share

per

share

per

share

per

share

per

share

(In $ millions, except per share data)

Earnings (loss) from continuing operations attributable to Celanese Corporation

45

0.41

(1,144

)

(10.44

)

25

0.23

(1,357

)

(12.39

)

207

1.89

(19

)

(0.17

)

Income tax provision (benefit)

33

(90

)

(15

)

(7

)

(77

)

9

Earnings (loss) from continuing operations before tax

78

(1,234

)

10

(1,364

)

130

(10

)

Certain Items attributable to Celanese Corporation (Table 8)

23

1,639

34

1,520

42

43

Refinancing and related expenses

68

36

32

Adjusted earnings (loss) from continuing operations before tax

101

473

80

156

172

65

Income tax (provision) benefit on adjusted earnings(1)

(8

)

(36

)

(6

)

(9

)

(15

)

(6

)

Adjusted earnings (loss) from continuing operations(2)

93

0.85

437

3.98

74

0.67

147

1.34

157

1.43

59

0.54

Diluted shares (in millions)(3)

Weighted average shares outstanding

109.7

109.5

109.6

109.6

109.5

109.4

Incremental shares attributable to equity awards

0.3

0.2

0.2

0.2

Total diluted shares

110.0

109.7

109.8

109.6

109.7

109.4

______________________________

(1)

Calculated using adjusted effective tax rates (Table 3a) as follows:

Q1 '26

2025

Q4 '25

Q3 '25

Q2 '25

Q1 '25

Adjusted effective tax rate

8

8

8

6

9

9

(2)

Excludes the immediate recognition of actuarial gains and losses and the impact of actual vs. expected plan asset returns.

Actual Plan

Asset Returns

Expected Plan

Asset Returns

(In percentages)

2025

7.8

5.3

(3)

Potentially dilutive shares are included in the adjusted earnings per share calculation when adjusted earnings are positive.

Table 3a

Adjusted Tax Rate - Reconciliation of a Non-GAAP Measure - Unaudited

Estimated

Actual

2026

2025

(In percentages)

U.S. GAAP annual effective tax rate

16

7

Discrete quarterly recognition of GAAP items(1)

(6

)

17

Tax impact of other charges and adjustments(2)

1

(12

)

Utilization of foreign tax credits

(1

)

Changes in valuation allowances, excluding impact of other charges and adjustments(3)

(3

)

(12

)

Other, includes effect of discrete current year transactions(4)

1

8

Adjusted tax rate

8

8

______________________________

Note: As part of the year-end reconciliation, we will update the reconciliation of the GAAP effective tax rate for actual results.

(1)

Such as changes in tax laws (including U.S. tax reform), deferred taxes on outside basis differences, changes in uncertain tax positions and prior year audit adjustments.

(2)

Reflects the tax impact on pre-tax adjustments presented in Certain Items (Table 8), which are excluded from pre-tax income for adjusted earnings per share purposes.

(3)

Reflects changes in valuation allowances related to changes in judgment regarding the realizability of deferred tax assets or current year operations, excluding other charges and adjustments.

(4)

Includes tax impacts related to full-year actual tax opportunities and related costs, as well as current year realization of U.S. GAAP benefits deferred in prior years.

Table 4

Net Sales by Segment - Unaudited

Q1 '26

2025

Q4 '25

Q3 '25

Q2 '25

Q1 '25

(In $ millions)

Engineered Materials

1,325

5,390

1,277

1,384

1,442

1,287

Acetyl Chain

1,036

4,232

940

1,061

1,115

1,116

Intersegment eliminations(1)

(24

)

(78

)

(13

)

(26

)

(25

)

(14

)

Net sales

2,337

9,544

2,204

2,419

2,532

2,389

______________________________

(1)

Includes intersegment sales primarily related to the Acetyl Chain.

Table 4a

Factors Affecting Segment Net Sales Sequentially - Unaudited

Three Months Ended March 31, 2026 Compared to Three Months Ended December 31, 2025

Volume

Price

Currency

Total

(In percentages)

Engineered Materials

3

1

4

Acetyl Chain

8

1

1

10

Total Company

5

1

6

Three Months Ended December 31, 2025 Compared to Three Months Ended September 30, 2025

Volume

Price

Currency

Total

(In percentages)

Engineered Materials

(6

)

(2

)

(8

)

Acetyl Chain

(10

)

(1

)

(11

)

Total Company

(7

)

(2

)

(9

)

Three Months Ended September 30, 2025 Compared to Three Months Ended June 30, 2025

Volume

Price

Currency

Total

(In percentages)

Engineered Materials

(6

)

1

1

(4

)

Acetyl Chain

(2

)

(4

)

1

(5

)

Total Company

(4

)

(1

)

1

(4

)

Three Months Ended June 30, 2025 Compared to Three Months Ended March 31, 2025

Volume

Price

Currency

Total

(In percentages)

Engineered Materials

9

3

12

Acetyl Chain

(1

)

(2

)

3

Total Company

4

(1

)

3

6

Three Months Ended March 31, 2025 Compared to Three Months Ended December 31, 2024

Volume

Price

Currency

Total

(In percentages)

Engineered Materials

2

(1

)

1

Acetyl Chain

3

(1

)

(1

)

1

Total Company

2

(1

)

1

Table 4b

Factors Affecting Segment Net Sales Year Over Year - Unaudited

Three Months Ended March 31, 2026 Compared to Three Months Ended March 31, 2025

Volume

Price

Currency

Total

(In percentages)

Engineered Materials

(1

)

4

3

Acetyl Chain

(7

)

(4

)

4

(7

)

Total Company

(3

)

(3

)

4

(2

)

Three Months Ended December 31, 2025 Compared to Three Months Ended December 31, 2024

Volume

Price

Currency

Total

(In percentages)

Engineered Materials

(2

)

3

1

Acetyl Chain

(10

)

(7

)

2

(15

)

Total Company

(6

)

(3

)

2

(7

)

Three Months Ended September 30, 2025 Compared to Three Months Ended September 30, 2024

Volume

Price

Currency

Total

(In percentages)

Engineered Materials

(8

)

(1

)

2

(7

)

Acetyl Chain

(4

)

(8

)

1

(11

)

Total Company

(6

)

(4

)

1

(9

)

Three Months Ended June 30, 2025 Compared to Three Months Ended June 30, 2024

Volume

Price

Currency

Total

(In percentages)

Engineered Materials

(3

)

(1

)

2

(2

)

Acetyl Chain

(2

)

(7

)

2

(7

)

Total Company

(2

)

(4

)

2

(4

)

Three Months Ended March 31, 2025 Compared to Three Months Ended March 31, 2024

Volume

Price

Currency

Total

(In percentages)

Engineered Materials

(4

)

(2

)

(1

)

(7

)

Acetyl Chain

(6

)

(4

)

(1

)

(11

)

Total Company

(5

)

(3

)

(1

)

(9

)

Table 4c

Factors Affecting Segment Net Sales Year Over Year - Unaudited

Year Ended December 31, 2025 Compared to Year Ended December 31, 2024

Volume

Price

Currency

Total

(In percentages)

Engineered Materials

(4

)

(1

)

1

(4

)

Acetyl Chain

(6

)

(6

)

1

(11

)

Total Company

(4

)

(4

)

1

(7

)

Table 5

Free Cash Flow - Reconciliation of a Non-GAAP Measure - Unaudited

Q1 '26

2025

Q4 '25

Q3 '25

Q2 '25

Q1 '25

(In $ millions, except percentages)

Net cash provided by (used in) investing activities

425

(349

)

(104

)

(59

)

(88

)

(98

)

Net cash provided by (used in) financing activities

(3

)

(513

)

(324

)

(118

)

(116

)

45

Net cash provided by (used in) operating activities

76

1,146

252

447

410

37

Capital expenditures on property, plant and equipment

(66

)

(343

)

(84

)

(64

)

(93

)

(102

)

Contributions from/(Distributions) to NCI

(7

)

(30

)

(8

)

(8

)

(6

)

(8

)

Free cash flow(1)

3

773

160

375

311

(73

)

Net sales

2,337

9,544

2,204

2,419

2,532

2,389

Free cash flow as % of Net sales

0.1

%

8.1

%

7.3

%

15.5

%

12.3

%

(3.1

)%

______________________________

(1)

Free cash flow is a liquidity measure used by the Company and is defined by the Company as net cash provided by (used in) operating activities, less capital expenditures on property, plant and equipment, and adjusted for contributions from or distributions to our NCI joint ventures.

Table 6

Cash Dividends Received - Unaudited

Q1 '26

2025

Q4 '25

Q3 '25

Q2 '25

Q1 '25

(In $ millions)

Dividends from equity method investments

54

139

47

40

21

31

Dividends from equity investments without readily determinable fair values

1

122

40

40

41

1

Total

55

261

87

80

62

32

Table 7

Net Debt - Reconciliation of a Non-GAAP Measure - Unaudited

Q1 '26

2025

Q4 '25

Q3 '25

Q2 '25

Q1 '25

(In $ millions)

Short-term borrowings and current installments of long-term debt - third party and affiliates

1,741

1,204

1,204

1,199

252

406

Long-term debt, net of unamortized deferred financing costs

10,813

11,394

11,394

11,655

12,689

12,378

Total debt

12,554

12,598

12,598

12,854

12,941

12,784

Cash and cash equivalents

(1,758

)

(1,263

)

(1,263

)

(1,440

)

(1,173

)

(951

)

Net debt

10,796

11,335

11,335

11,414

11,768

11,833

Table 8

Certain Items - Unaudited

The following Certain Items attributable to Celanese Corporation are included in Net earnings (loss) and are adjustments to non-GAAP measures:

Q1 '26

2025

Q4 '25

Q3 '25

Q2 '25

Q1 '25

Income Statement Classification

(In $ millions)

Exit and shutdown costs

44

98

29

10

27

32

Cost of sales / SG&A / Other (charges) gains, net / Gain (loss) on disposition of businesses and assets, net / Non-operating pension and other postretirement employee benefit (expense) income

Asset impairments

1,513

27

(1)

1,486

(2)

Cost of sales / Other (charges) gains, net

Impact from plant incidents and natural disasters

11

3

3

Cost of sales

Mergers, acquisitions and dispositions

15

52

23

12

12

5

Cost of sales / SG&A

Actuarial (gain) loss on pension and postretirement plans

(49

)

(49

)

Cost of sales / SG&A / Non-operating pension and other postretirement employee benefit (expense) income

Legal settlements and commercial disputes

3

17

1

11

2

3

Cost of sales / SG&A / Other (charges) gains, net

(Gain) loss on disposition of businesses and assets

(50

)

Gain (loss) on disposition of businesses and assets, net

Other

5

3

1

1

Cost of sales / SG&A

Certain Items attributable to Celanese Corporation

23

1,639

34

1,520

42

43

______________________________

(1)

Related to impairment of certain long-lived assets arising from unused parcels of property subsequently sold.

(2)

Related to impairment of goodwill and certain trade names, primarily Zytel®, arising from our annual goodwill and indefinite-lived intangible assets impairment tests.

Table 9

Return on Invested Capital (Adjusted) - Presentation of a Non-GAAP Measure - Unaudited

2025

(In $ millions,

except percentages)

Net earnings (loss) attributable to Celanese Corporation

(1,165

)

Adjusted EBIT (Table 1)

1,150

Adjusted effective tax rate (Table 3a)

8

%

Adjusted EBIT tax effected

1,058

2025

2024

Average

(In $ millions, except percentages)

Short-term borrowings and current installments of long-term debt - third parties and affiliates

1,204

1,501

1,353

Long-term debt, net of unamortized deferred financing costs

11,394

11,078

11,236

Celanese Corporation shareholders' equity

4,049

5,129

4,589

Invested capital

17,178

Return on invested capital (adjusted)

6.2

%

Net earnings (loss) attributable to Celanese Corporation as a percentage of invested capital

(6.8

)%

Investor Relations

Bill Cunningham

Phone: +1 302 772 5231

[email protected]

Media - U.S.

Jamaison Schuler

Phone: +1 972 443 4400

[email protected]

Media - Europe

Petra Czugler

Phone: +49 69 45009 1206

[email protected]

Media - Asia

Maria Xia

Phone: +86 21 3861 9368

[email protected]

Source: Celanese Corporation

Categories

Business Wire Press Releases